Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19:A case report and review of the literature
作者机构：State Key Laboratory for Diagnosis and Treatment of Infectious DiseasesNational Clinical Research Center for Infectious DiseasesCollaborative Innovation Center for Diagnosis and Treatment of Infectious DiseasesThe First Affiliated HospitalCollege of MedicineZhejiang UniversityHangzhou 310003Zhejiang ProvinceChina
出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)
年 卷 期：2021年第9卷第7期
页 面：1705-1713页
核心收录：
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金：Zhejiang Basic Public Welfare Research Program No.LQ20H030012
主 题：COVID-19 Human menstrual blood-derived stem cells Immunoregulatory therapy Inflammatory response Cytokine storm Case report
摘 要：BACKGROUND The coronavirus disease 2019(COVID-19)caused by novel coronavirus 2019 in December 2019 has spread all around the globe and has caused a *** is still no current effective guidance on the clinical management of *** stem cell therapy has been shown to be one of the therapeutic approaches to alleviate pneumonia and symptoms through their immunomodulatory effect in COVID-19 *** SUMMARY We describe the first confirmed case of COVID-19 in Hangzhou to explore the role of human menstrual blood-derived stem cells(MenSCs)in the treatment of ***,we review the immunomodulation effect including nonspecific and specific immune functions of MenSCs for the therapy of *** MenSCs can be helpful to find a promising therapeutic approach for COVID-19.
维普期刊数据库